Answers are grounded in this paper and cite their sources.
Examines cGAS-STING involvement in neurodegeneration, suggesting it may drive neuroinflammation.
• cGAS-STING switches from antiviral guardian to driver of sterile neuroinflammation in the CNS. • Microglial STING activation triggers pathological synapse pruning and neurotoxic astrocyte conversion. • Endogenous nuclear, mitochondrial, and retrotransposon DNA hijack cGAS-STING in aging and diseased brain. • cGAS-STING acts as a common inflammatory amplifier in ALS/FTD, Alzheimer's, Parkinson's, and Huntington's. • Effective therapy needs CNS delivery, biomarkers, and combination with upstream DNA-reducing strategies.
No takes yet. Share an insight, caveat, or question.
Oriquat et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: